S3-Leitlinie Demenzen (Kurzversion) - AWMF

Literatur 51
24. Hachinski V, Iadecola C, Petersen RC, et al.: National Institute of Neurological Disorders and Stroke-
Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006; 37: 2220-
2241.
25. Rascovsky K, Salmon DP, Hansen LA, et al.: Disparate letter and semantic category fluency deficits in
autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology 2007; 21: 20-30.
26. Gainotti G, Marra C, Villa G: A double dissociation between accuracy and time of execution on attentional
tasks in Alzheimer's disease and multi-infarct dementia. Brain 2001;124: 731-738.
27. Oguro H, Yamaguchi S, Abe S, et al.: Differentiating Alzheimer's disease from subcortical vascular dementia
with the FAB test. J Neurol 2006; 253: 1490-1494.
28. Graham NL, Emery T, Hodges JR: Distinctive cognitive profiles in Alzheimer's disease and subcortical
vascular dementia. J Neurol Neurosurg Psychiatry 2004; 75: 61-71.
29. Reed BR, Mungas DM, Kramer JH, et al.: Profiles of neuropsychological impairment in autopsy-defined
Alzheimer's disease and cerebrovascular disease. Brain 2007; 130: 731-739.
30. Garbutt S, Matlin A, Hellmuth J, et al.: Oculomotor function in frontotemporal lobar degeneration, related
disorders and Alzheimer's disease. Brain 2008; 131: 1268-1281.
31. Marra C, Quaranta D, Zinno M, et al.: Clusters of cognitive and behavioral disorders clearly distinguish
primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease. Dement Geriatr Cogn
Disord 2007; 24: 317-326.
32. Fukui T, Lee E: Progressive agraphia can be a harbinger of degenerative dementia. Brain Lang 2008; 104:
201-210.
33. Mori E, Shimomura T, Fujimori M, et al.: Visuoperceptual impairment in dementia with Lewy bodies. Arch
Neurol 2000; 57: 489-493.
34. Williams VG, Bruce JM, Westervelt HJ, et al.: Boston naming performance distinguishes between Lewy
body and Alzheimer's dementias. Arch Clin Neuropsychol 2007; 22: 925-931.
35. Ballard C, O'Brien J, Gray A, et al.: Attention and fluctuating attention in patients with dementia with Lewy
bodies and Alzheimer disease. Arch Neurol 2001; 58: 977-982.
36. Troster AI: Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with
dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.
Neuropsychol Rev 2008;18: 103-119.
37. Lees AJ, Smith E: Cognitive deficits in the early stages of Parkinson's disease. Brain.1983;106: 257-270.
38. Metzler-Baddeley C: A review of cognitive impairments in dementia with Lewy bodies relative to
Alzheimer's disease and Parkinson's disease with dementia. Cortex 2007; 43: 583-600.
39. Caputo M, Monastero R, Mariani E, et al.: Neuropsychiatric symptoms in 921 elderly subjects with
dementia: a comparison between vascular and neurodegenerative types. Acta Psychiatr Scand 2008; 117:
455-464.
40. Aalten P, Verhey FR, Boziki M, et al.: Consistency of neuropsychiatric syndromes across dementias: results
from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord. 2008; 25: 1-8.
41. Toyota Y, Ikeda M, Shinagawa S, et al.: Comparison of behavioral and psychological symptoms in earlyonset
and late-onset Alzheimer's disease. Int J Geriatr Psychiatry 2007; 22: 896-901.
42. Hargrave R, Geck LC, Reed B, Mungas D.: Affective behavioural disturbances in Alzheimer's disease and
ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2000; 68: 41-46.
43. Bozeat S, Gregory CA, Ralph MA, Hodges JR: Which neuropsychiatric and behavioural features distinguish
frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg
Psychiatry 2000; 69: 178-186.
44. Nyatsanza S, Shetty T, Gregory C, et al.: A study of stereotypic behaviours in Alzheimer's disease and frontal
and temporal variant frontotemporal dementia. J Neurol Neurosurg Psychiatry 2003; 74: 1398-1402.
45. Banks SJ, Weintraub S: Neuropsychiatric symptoms in behavioral variant frontotemporal dementia and
primary progressive aphasia. J Geriatr Psychiatry Neurol 2008; 21: 133-141.
46. Ballard C, Holmes C, McKeith I, et al.: Psychiatric morbidity in dementia with Lewy bodies: a prospective
clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 1999; 156:
1039-1045.
47. Engelborghs S, Maertens K, Nagels G, et al.: Neuropsychiatric symptoms of dementia: cross-sectional
analysis from a prospective, longitudinal Belgian study. Int J Geriatr Psychiatry 2005; 20: 1028-1037.
48. Shinagawa S, Adachi H, Toyota Y, et al.: Characteristics of eating and swallowing problems in patients who
have dementia with Lewy bodies. Int Psychogeriatr 2009; 21: 520-525.
S3-Leitlinie "Demenzen": Kurzversion (November 2009)
Die "Leitlinien" der Wissenschaftlichen Medizinischen Fachgesellschaften sind systematisch entwickelte
Hilfen für Ärzte zur Entscheidungsfindung in spezifischen Situationen. Sie beruhen auf aktuellen wissenschaftlichen
Erkenntnissen und in der Praxis bewährten Verfahren und sorgen für mehr Sicherheit in der Medizin, sollten aber auch
ökonomische Aspekte berücksichtigen. Die "Leitlinien" sind für Ärzte rechtlich nicht bindend und haben daher weder
haftungsbegründende noch haftungsbefreiende Wirkung.
Die AWMF erfasst und publiziert die Leitlinien der Fachgesellschaften mit größtmöglicher Sorgfalt - dennoch kann die
AWMF für die Richtigkeit - insbesondere von Dosierungsangaben - keine Verantwortung übernehmen.